You are here: Industry Insights > AGC Biologics

News List

Takara Bio, AGC Biologics Enter Plasmid DNA Mfg. Pact contractpharma
May 26, 2020
AGC to manufacture plasmid DNA intermediate for COVID-19 vaccine candidate.
AGC Biologics Inks Manufacturing Deal with Faron contractpharma
May 07, 2020
The CDMO will manufacture novel precision cancer immunotherapy treatment Clevegen.
AGC Biologics, AdaptVac Partner to Develop COVID-19 Vaccine contractpharma
April 28, 2020
Will leverage AdaptVac's Virus-Like Particle (VLP) technology that could provide a solution to protect against new SARS-CoV-2 infections.
DCAT Week Cancelled, AGC Biologics to Meet Virtually with Industry Leaders prnasia
March 20, 2020
Due to the recent cancellation of DCAT Week, AGC Biologics will be meeting virtually with industry leaders who planned to attend the event.
AGC Biologics to Participate in Virtual BIO-Europe Spring prnasia
March 20, 2020
AGC Biologics is pleased to be a gold sponsor of BIO-Europe Spring, Europe's largest springtime biotech partnering event.
AGC Biologics appoints new General Manager for Japan biospectrumasia
September 26, 2019
Kagami-san has the expertise and experience to lead our Chiba site in the growth and achievement of our stated goals and objectives.
Dr. Gustavo Mahler Resigns as Chief Executive Officer of AGC Biologics, Patricio Massera to Succeed as CEO Effective May 1st, 2019 en-cphi.cn
April 03, 2019
AGC Biologics today announces a change in executive leadership. Dr. Gustavo Mahler has decided to leave his position as CEO effective April 30th, 2019 after a 10 year tenure with CMC Biologics and AGC Biologics.
AGC Biologics increases manufacturing capacity at Denmark biospectrum
September 10, 2018
The addition of this proprietary bioreactor configuration will enable more flexible, innovative, and customized cGMP production capabilities, offering scales from 2000 L to 12000 L within a single run
AGC Biologics Expands Capacity at Denmark Facility contractpharma
August 24, 2018
As part of its global expansion strategy, AGC Biologics is increasing manufacturing capacity at its Copenhagen, Denmark facility.
AGC Biologics Appoints New Site Head/General Manager of Bothell, WA Operations prnasia
April 13, 2018
AGC Biologics, announced today the appointment of Dr. Jin Wang as Site Head/General Manager of its Bothell, Washington operations. Ms

Previous page 1 2 3 4 Next page